Folate‐PEG‐PROTAC Micelles for Enhancing Tumor‐Specific Targeting Proteolysis In Vivo
Advanced Healthcare Materials · 2024-08 · 13 (20)
DOI: 10.1002/adhm.202400109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 03.05.2024. Verfasst von Junhui Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. Hauptthemen laut MEDLINE: Micelles, Folic Acid, Polyethylene Glycols, Proteolysis. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Natural Science Foundation of China, Guizhou Provincial Science and Technology Support Plan, National Natural Science Foundation of China.
Abstract (Originalsprache)
Proteolysis targeting chimeras (PROTACs) technology is rapidly developed as a novel and selective medicinal strategy for the degradation of cellular proteins in cancer therapy. However, the applications of PROTACs as heterobifunctional molecules are largely limited by high molecular weight, low bioavailability, poor permeability, insufficient targeting, and low efficacy in vivo. Herein, self‐assembling micelles of FA‐PEG‐PROTAC are designed for cancer cell selective targeting and reductive‐response proteolysis in tumor‐bearing mice. FA‐PEG‐PROTAC is prepared by conjugating folic acid (FA)‐PEG with EGFR‐targeting PROTAC via a disulfide bond. The FA‐PEG‐PROTAC micelles, formed by self‐assembling, are demonstrated to significantly improve tumor targeting efficacy and exhibit excellent anti‐tumor efficacy in the mouse xenograft model compared to the traditional PROTACs. The strategy of applying self‐assembled FA‐PEG‐PROTAC micelles in tumor therapy can not only improve targeted proteolysis efficiency but also broaden applications in the development of PROTAC‐based drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
- Department of Pharmacy, Tongren Polytechnic College, Tongren, 554300, China.
- Institute of the Higher Education Edible and Medicinal Fungi Engineering Research Center, Tongren, 554300, China.
ORCID-Profile: Xiang Ma
Förderung
- Natural Science Foundation of China
- Guizhou Provincial Science and Technology Support Plan
- National Natural Science Foundation of China
Zitieren
APA
Ma, J., Fang, L., Sun, Z., Li, M., Fan, T., Xiang, G., & Ma, X. (2024). Folate‐PEG‐PROTAC Micelles for Enhancing Tumor‐Specific Targeting Proteolysis In Vivo. Advanced Healthcare Materials, 13(20). https://doi.org/10.1002/adhm.202400109
Vancouver
Ma J, Fang L, Sun Z, Li M, Fan T, Xiang G, et al. Folate‐PEG‐PROTAC Micelles for Enhancing Tumor‐Specific Targeting Proteolysis In Vivo. Advanced Healthcare Materials. 2024;13(20). doi:10.1002/adhm.202400109
BibTeX
@article{Ma2024,
author = {Ma, Junhui and Fang, Lei and Sun, Zhengjun and Li, Meijing and Fan, Ting and Xiang, Guangya and Ma, Xiang},
title = {Folate‐PEG‐PROTAC Micelles for Enhancing Tumor‐Specific Targeting Proteolysis In Vivo},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {20},
doi = {10.1002/adhm.202400109}
}
EUVIMED